Asia Pacific IVF Services Market to Grow at a CAGR of 12.2% to reach US$ 6,512.44 million from 2020 to 2027

The Asia Pacific IVF services market is expected to reach US$ 6,512.44 million by 2027 from US$ 2,670.72 million in 2019; it is estimated to grow at a CAGR of 12.2% from 2020 to 2027.

The growth of the market is attributed to increasing incidence of infertility, rising number of fertility clinics and infertility services with government support and growing number of products launches and developments. However, the high procedural cost of assisted reproductive techniques hinders the market growth.

IVF or In Vitro Fertilization is a reproductive technology in which the ova from a woman's ovaries and the sample of sperm from a male are retrieved and manually diffused externally in a laboratory glass dish. After the fertilization, these fertile eggs undergo embryo culture for a few days and are transferred to the same or another woman's uterus to establish a successful pregnancy. The fertility rate is steadily declining globally, owing to various factors, such as the growing trend of late marriages and increasing age-related infertility. According to United Nations projections, Australia's birth rate in 2020 was 12.56 births per 1000 people, a 1.25% decline from 2019. Thus, the declining fertility rate leads to a significant increase in demand for in vitro fertilization (IVF) services that determine the fertility window in males and females. Additionally, a rising number of fertility clinics and infertility services with government support and an increasing number of product launches are projected to drive the IVF services market.

The COVID-19 outbreak pandemic is adversely affecting countries in Asia Pacific. Along with an increase in global developments, the growing concern of coronavirus disease (COVID-19) will impact those undergoing fertility treatments. Therefore, the Government of various countries has outlined some guidelines by suggestions on managing patients who are undergoing infertility therapy or the desiring pregnancy. With recommendations such as elude traveling and getting an infection, patients are avoiding the treatment. Hence, the market for IVF is likely to affect. However, in the long run, the market is expected to boost the demand, as IVF centers are reopening for the healthcare services for patients other than COVID 19.

Asia Pacific IVF Services Market Segmentation:

By Cycle Type

• Fresh IVF Cycles
• Thawed IVF Cycles
• Donor Egg IVF Cycles

By End User

• Fertility Clinics
• Hospitals
• Surgical Centres and Clinical Research Institutes

By Country

• India
• Australia
• Japan
• China
• South Korea
• Rest of Asia Pacific

Company Profiles

• CCRM Fertility.
• Medic over
• Prelude Fertility, Inc
• Gift ov life 

Asia Pacific IVF Services Report Scope